Triangle Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Triangle Pharmaceuticals Ownership

Who owns Triangle Pharmaceuticals?

Triangle Pharmaceuticals is owned by Gilead Sciences. It was acquired on January 23, 2003.

Was Triangle Pharmaceuticals formerly PE-backed?

Yes. Triangle Pharmaceuticals was formerly owned by 1 private investor.

Triangle Pharmaceuticals Business Overview

Where is Triangle Pharmaceuticals headquartered?

Triangle Pharmaceuticals is headquartered in Durham, North Carolina.

How many employees does Triangle Pharmaceuticals have?

Triangle Pharmaceuticals has 115 employees.

What sector is Triangle Pharmaceuticals in?

Triangle Pharmaceuticals is a life science company.

Life Science M&A Summary in 2003

Out of 60 sectors in the Mergr database, life science ranked 12 in number of deals in 2003. The largest life science acquisition in 2003 was Pharmacia - which was acquired by Pfizer for $60.0B.

Join Mergr to view all 42 acquisitions of life science companies in 2003, including 14 acquisitions by private equity firms, and 28 by strategics.

Triangle Pharmaceuticals, Inc.

4 University Place, 4611 University Drive,
Durham, North Carolina 27707
United States,
(919) 493-5980
www.tripharm.com

Triangle Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing effective solutions for serious viral disease, with a particular focus on therapies for the human immunodeficiency virus (HIV), including the acquired immunodeficiency syndrome (AIDS) and the hepatitis B virus (HBV).


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.